STANDARD BIOTOOLS INC. — Director's Dealing 2023

May 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-05-18

Reporting Person: Black Jeffrey G. (SVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-18	Common Stock	P	43492	$2.2157	Acquired	43492	Direct
2023-05-19	Common Stock	P	42492	$2.2878	Acquired	85984	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.14 to $2.28. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $2.23 to $2.32. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.